Crystalline beta2 adrenergic receptor agonist
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Apr 7, 2005
app pub date -
Jul 25, 2003
filing date -
Jul 26, 2002
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
The invention provides a crystalline salt form of a novel .beta..sub.2 adrenergic receptor agonist. The invention also provides pharmaceutical compositions comprising the crystalline form, formulations containing the pharmaceutical compositions, methods of using the crystalline salt form to treat diseases associated with .beta..sub.2 adrenergic receptor activity, and processes useful for preparing such a crystalline compound.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully